GSK2374697 / GSK  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK2374697 / GSK
NCT01545570: A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers

Completed
1
82
US
GSK2376497, 0.9% sodium chloride
GlaxoSmithKline
Diabetes Mellitus, Type 2
12/12
12/12

Download Options